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Abstract 
Necrotizing and granulomatous meningoencephalitis are common central nervous system dis-
eases known to affect canines. To date, necrotizing granulomatous meningoencephalitis has 
yet to be described in humans. Current studies of presumed pathogenesis and possible treat-
ment options have only been described in canines. This is a case report of a 55-year-old female 
patient who was diagnosed with necrotizing granulomatous meningoencepha litis in the set-
ting of new-onset neurological symptoms without any infectious or malignant source. 
 © 2018 The Author(s) 
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Introduction 
Chronic necrotizing and granulomatous meningoencephalitis are idiopathic inflamma-
tory diseases that commonly affect the central nervous system of canines, however, have not 
been identified in humans yet. These diseases have been associated with specific dog breeds, 
causing a progressive fatal disease with consistent neuropathological changes [1]. Canine me-
ningoencephalitis is further classified into necrotizing and granulomatous meningoencepha-
litis based on pathological findings, yet these subclasses are suspected to share a possibly au-
toimmune pathogenesis [2]. Although these idiopathic inflammatory central nervous system 
diseases have been identified and investigated within the canine species, necrotizing granu-
lomatous meningoencephalitis has not been readily identified and studied in h umans. Here, 
we report a case of chronic necrotizing granulomatous meningoencephalitis in an adult female 
patient. 
Case Report 
The patient is a 55-year-old right-handed female with a past medical history of previous 
diagnosis of chronic lymphocytic leukemia, and recurrent TB exposure presenting with new-
onset daily frontal headaches. She originally presented to her primary care physician with in-
termittent burning left frontal headaches that were worse with exertion and without associ-
ated focal neurologic deficit. Initial neurological examination was unremarkable. MRI of the 
brain revealed an 11-mm left frontal lobe enhancing lesion with surrounding vasogenic 
edema, as well as multiple punctate bilateral cortical/subcortical enhancing lesions (Fig. 1). 
Her headaches began to worsen in intensity and frequency and were associated with new -
onset right facial tingling and intermittent bilateral upper and lower extremity pain. Extensive 
infectious, autoimmune, and neoplastic workup was completed and was unremarkable. Ma-
lignancy workup included CT of the chest, abdomen, and pelvis, followed by a whole -body 
bone scan, PET-CT, and flow cytometry which were all negative for malignancy. A summary of 
the infectious and autoimmune workup can be found in Table 1. 
The patient was referred to neurosurgery for open brain biopsy targeting the left frontal 
enhancing lesion. Postoperative neurologic examination demonstrated a mild expressive 
aphasia with word finding difficulties. Neuropathology revealed chronic granulomatous in-
flammation of the brain and meninges. The granulomas noted within the meninges showed 
central necrosis surrounded by a rim of lymphocytes, plasma cells, and epithelioid histiocytes 
in addition to eosinophils and giant cells. Marked fibrosis and burnt-out granulomas were 
seen within both the meninges and brain tissue with dense perivascular lymphoplasmacytic 
infiltrate along with reactive gliosis within the cerebral cortex. These findings were consistent 
with chronic necrotizing granulomatous meningoencephalitis. There were no findings on bi-
opsy consistent with mycobacterial infection.  
The patient was treated with intravenous 1,000 mg Solumedrol for 3 days followed by a 
6-week prednisone taper. Over the next 6 months, the patient remained clinically stable with 
mild expressive aphasia. Six months after treatment, she began having staring spells that 
started with a strange feeling. No EEG correlate was noted on long-term EEG monitoring; how-
ever, she was started on Lamictal for high suspicion of focal seizures, with complete resolution 
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of symptoms. She remained clinically and radiographically stable without additional treat-
ment for 4 years until the most recent MRI in 2018 suggesting recurrence (Fig. 2). 
Discussion 
Chronic necrotizing granulomatous meningoencephalitis, although extensively studied in 
canines, has yet to be described in humans. Canines can display a wide variety of clinical symp-
toms depending on the location of the lesions. Common symptoms of necrotizing meningoen-
cephalitis in canines include seizures, paresis, ataxia, visual defects, lethargy, behavioral 
changes, excessive walking in circles, and death [3, 4]. Although necrotizing meningoenceph-
alitis and granulomatous meningoencephalitis can be classified as two distinct processes, the 
proportion of inflammatory cells does not differ among them, suggesting that they are a spec-
trum of the same disease with shared pathogenesis [5]. Pathology of these diseases consist of 
necrosis with infiltration of lymphocytes, plasma cells, and histiocytes within the leptomenin-
ges and the cerebral cortex [5]. Granulomatous lesions with epithelioid cells are seen in addi-
tion to perivascular cuffs consisting of lymphocytes, plasma cells, and macrophages [5]. 
Although the pathogenesis remains unclear, research suggests a possible autoimmune 
mediated delayed-type hypersensitivity response due to the significant presence of CD3  
T-lymphocytes and major histocompatibility complex class II [5, 6]. It is theorized that the 
granulomatous nature of the disease further supports an immune mediated etiology. Variants 
of meningoencephalitis can be associated with specific canine breeds with a higher predilec-
tion for females, although both sexes are affected [7]. 
Studies have yet to identify a single infectious, environmental, or genetics basis, suggest-
ing that multiple factors play a role in disease pathogenesis [6]. Genetic predisposition has 
been identified in certain breeds [1]. Common infectious causes of canine central nervous sys-
tem disease, such as canine distemper, Cryptococcus neoformans, Ehrlichia canis, Neospora 
caninum, Rickettsia rickettsii, and Toxoplasma gondii, have yet to be isolated in canines with 
necrotizing granulomatous meningoencephalitis [4]. Mycoplasma canis has been isolated at a 
higher frequency from canines with necrotizing granulomatous meningoencephalitis; how-
ever, this difference was not found to be statistically significant when compared to controls 
[1]. There has yet to be correlation with any viral infections as well, but it remains unclear if 
possible past exposure could potentiate these diseases [3].  
Overall, definitive diagnosis is made postmortem during autopsy of deceased or eu-
thanized canines. It remains difficult to diagnose canines prior to autopsy but living diagnosis 
can be supported by CSF findings that exclude other infectious etiologies. Additionally, MRI or 
CT findings consisting of solitary or multiple contrast-enhancing lesions can back up the diag-
nosis when suspicious for inflammatory meningoencephalitis [7]. 
There is currently no gold standard treatment for necrotizing granulomatous meningoen-
cephalitis in canines as treatment protocols are largely based on case reports alone and over-
all it represents a broad spectrum of diseases [6]. The typical treatment for these canines in-
cludes immunosuppression with corticosteroids, although neurological symptoms can recur 
after treatment [7]. Other secondary immunomodulatory drugs such as cyclosporine, cytosine 
arabinoside, leflunomide, lomustine, and mycophenolate mofetil show promising results but 
require further evaluation for efficacy [6]. Additionally, use of antiepileptics are suggested in 
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canines with seizures [2]. Despite treatment, the prognosis remains poor, yet canines with 
focal disease tend to survive longer than those with disseminated disease [6].  
After a thorough literature review, this is the first case of human chronic necrotizing gran-
ulomatous meningoencephalitis to be reported. The similar pathological findings in canines 
with necrotizing and granulomatous meningoencephalitis suggests that this predominantly 
canine disease can afflict humans as well. Further research is necessary to determine patho-
genesis in both humans and canines. This case demonstrates that the use of glucocorticoids 
for the treatment of necrotizing granulomatous meningoencephalitis, as in canines, may slow 
progression of the disease. Our patient remained clinically stable with no evidence of radio-
logic progression for 4 years after initial steroid treatment. Further research is necessary to 
determine ideal treatment protocols and to further evaluate the use of immunomodulatory 
therapy in this disease entity.  
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Fig. 1. MRI of the brain with and without gadolinium at presentation. a–c T1 post contrast images demon-
strating nodular enhancement in the left frontal cortex (a), left parietal cortex (b), and right occipital cortex 
(c). d T2 imaging with vasogenic edema in the left frontal cortex with central hypointensity in the area of 
enhancement. e, f T2 FLAIR with bilateral hyperintensities largely surrounding the area of enhancement. 
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Fig. 2. MRI of the brain with and without gadolinium (4 years later). a–c T1 post contrast images demon-
strating new nodular enhancement in the left frontal cortex adjacent to biopsy site (a), two small lesions 
in the left parietal cortex (b), and new left anterior temporal cortex (c). d T2 imaging with vasogenic edema 
in the left frontal cortex with central hypointensity in the area of biopsy. e, f T2 FLAIR wit bilateral hyper-
intensities in the areas of enhancement. 
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Table 1. Summary of laboratory and imaging results 
     
     
Serum studies  CSF studies  Imaging/other 
        
        
CBC WBC – 16.27 k/μL 
Hgb – 14.3 g/dL 
Plt – 411 k/μL 
 Cell count RBC – 15 
lymphocyte – 1 
 CT of the chest, 
abdomen and 
pelvis 
mild bullous emphy-
sema, no primary 
malignancy or me-
tastases 
                HgbA1c 7.8%  Glucose 65 mg/dL  PET-CT mild increased 
asymmetric uptake 
in right tonsil 
                ANA negative  Protein 44 mg/dL  Nuclear medicine 
bone scan 
no evidence of skel-
etal metastases 
                Complement C3 – 161 mg/dL 
(ref. 90–180) 
C4 – 36 mg/dL 
(ref. 10–140) 
 Cytology benign  Mammogram  normal 
                SSA-SSB negative  Myelin basic  
protein 
<2 mg/L  
(ref. 0–4) 
 Colonoscopy  tubular adenoma 
                ANCA negative  IgG Index 0.42  
(ref. <0.66) 
 PPD negative 
                ESR 17 mm/h 
(ref. 0–20) 
 Oligoclonal bands 5 gamma-re-
stricted bands 
with serum cor-
relate 
 EEG ×4 left frontotemporal 
slowing without epi-
leptiform discharges 
                CRP 7.58 ml/L  
(ref. 0–5) 
 Culture anaerobic/aer-
obic 
no growth    
                ACE 6 U/L  
(ref. 9–67) 
 Gram stain no organisms or 
PMNs 
   
                FTA-ABS nonreactive  Fungal smear no yeast or hy-
phae 
   
                Quantiferon negative  Fungal culture no growth    
                Histoplasmosis/ 
blastomycosis IgG 
negative  Cryptococcal  
antigen 
negative    
                HIV negative negative       
                Hepatitis panel negative       
                SPEP normal       
        
        
 
 
 
